Guangdong Zhongsheng Pharmaceutical (002317.SZ) Earnings Analysis
Guangdong Zhongsheng Pharmaceutical (002317.SZ) next reports earnings on 2026-08-20. Last quarter (2026-04-30) it missed with EPS 0.12 CNY vs 0.13 CNY est (-7.7%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 76.50.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002317.SZ next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
002317.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.12 CNY | 0.13 CNY | -7.7% | Miss |
| 2025-10-30 | 0.07375 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.1 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.08 CNY | n/a | n/a | n/a |
| 2024-08-29 | 0.04232 CNY | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
002317.SZ valuation and analyst view
| Trailing P/E | 76.50 |
|---|---|
| Trailing EPS | 0.35218 CNY |
| Price / book | 5.41 |
| Dividend yield | 0.74% |
| Market cap | 23.63B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Guangdong Zhongsheng Pharmaceutical (002317.SZ)'s next earnings date?
Guangdong Zhongsheng Pharmaceutical is next scheduled to report on 2026-08-20.
Did 002317.SZ beat earnings last quarter?
In its 2026-04-30 report, 002317.SZ posted EPS of 0.12 CNY versus a 0.13 CNY estimate — a miss of 7.7%.
What is 002317.SZ's earnings track record?
Over the last 1 reported quarters with consensus data, 002317.SZ beat estimates 0 times (0%).
What is 002317.SZ's current P/E ratio and EPS?
002317.SZ trades at a trailing P/E of 76.50 on trailing EPS of 0.35218267989024316 CNY.
What do analysts rate 002317.SZ?
002317.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.